HomeCompaniesProfile

Atomwise

Artificial intelligence for drug discovery. 


Company Size

51 - 250 employees

Year Founded

Not Specified


About Atomwise

Atomwise is a preclinical tech-enabled biotech using machine learning for hit discovery, hit expansion, and lead optimization. We were the first team to apply convolutional neural networks to drug discovery. We focus on identifying and optimizing novel small molecule scaffolds and unlocking previously-undrugged protein targets.

Founders & Key People

Izhar Wallach

Izhar Wallach

Co-founder of Atomwise

Abraham Heifets

Abraham Heifets

Founder/CEO, Atomwise

Share This Profile

More Companies

Nomic Bio

Nomic is doing for proteins what Illumina has done for DNA

DigiBuild Software

We buy & track building materials for construction companies.

Aquarium Learning

We help ML teams improve their models by improving their datasets

Volta Labs, Inc.

Unlocking the utility of genomics for the world.

Panorama Education

Improving education for every student.

Overview

AI vision sensors for manufacturing

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.